Birth Outcomes for Pregnant Women With HIV Using Tenofovir-Emtricitabine EDITORIAL COMMENT

被引：0
|
作者：
Norton, Mary E.
机构：
来源：
OBSTETRICAL & GYNECOLOGICAL SURVEY | 2018年 / 73卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：513 / 515
页数：3
相关论文
共 50 条
  • [21] Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women Editorial Comment
    Berger, Richard E.
    JOURNAL OF UROLOGY, 2011, 185 (05): : 1729 - 1729
  • [22] Hip Structural Parameters over 96 Weeks in HIV-Infected Adults Switching Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine
    Haskelberg, Hila
    Pocock, Nicholas
    Amin, Janaki
    Ebeling, Peter Robert
    Emery, Sean
    Carr, Andrew
    PLOS ONE, 2014, 9 (04):
  • [23] HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women
    Marrazzo, Jeanne
    Tao, Li
    Becker, Marissa
    Leech, Ashley A.
    Taylor, Allan W.
    Ussery, Faith
    Kiragu, Michael
    Reza-Paul, Sushena
    Myers, Janet
    Bekker, Linda-Gail
    Yang, Juan
    Carter, Christoph
    de Boer, Melanie
    Das, Moupali
    Baeten, Jared M.
    Celum, Connie
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (11): : 930 - 937
  • [24] Successful use of darunavir, etravirine, enfuvirtide and tenofovir/emtricitabine in pregnant woman with multiclass HIV resistance
    Furco, Andre
    Gosrani, Bhairvi
    Nicholas, Sara
    Williams, Amanda
    Braithwaite, Wunmi
    Pozniak, Anton
    Taylor, Graham
    Asboe, David
    Lyall, Hermione
    Shaw, Andrew
    Kapembwa, Moses
    AIDS, 2009, 23 (03) : 434 - 435
  • [25] Small for gestational age birth outcomes in pregnant women with perinatally acquired HIV
    Jao, Jennifer
    Sigel, Keith M.
    Chen, Katherine T.
    Rodriguez-Caprio, Gabriela
    Posada, Roberto
    Shust, Gail
    Wisnivesky, Juan
    Abrams, Elaine J.
    Sperling, Rhoda S.
    AIDS, 2012, 26 (07) : 855 - 859
  • [26] Risk of Adverse Birth Outcomes in Two Cohorts of Pregnant Women With HIV in Zambia
    Price, Joan T.
    Sebastiao, Yuri, V
    Vwalika, Bellington
    Cole, Stephen R.
    Mbewe, Felistas M.
    Phiri, Winifreda M.
    Freeman, Bethany L.
    Kasaro, Margaret P.
    Peterson, Marc
    Rouse, Dwight J.
    Stringer, Elizabeth M.
    Stringer, Jeffrey S. A.
    EPIDEMIOLOGY, 2022, 33 (03) : 422 - 430
  • [27] Dolutegravir/tenofovir/emtricitabine (DTG/TDF/FTC) started in pregnancy is as safe as efavirenz/tenofovir/ emtricitabine (EFV/TDF/FTC) in nationwide birth outcomes surveillance in Botswana
    Zash, R.
    Jacobson, D.
    Mayondi, G.
    Diseko, M.
    Makhema, J.
    Mmalane, M.
    Gaolathe, T.
    Petlo, C.
    Holmes, L.
    Essex, M.
    Lockman, S.
    Shapiro, R.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2017, 20 : 105 - 106
  • [28] Tenofovir alafenamide use in pregnant and lactating women living with HIV
    Eke, Ahizechukwu C.
    Brooks, Kristina M.
    Gebreyohannes, Rahel D.
    Sheffield, Jeanne S.
    Dooley, Kelly E.
    Mirochnick, Mark
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2020, 16 (04) : 333 - 342
  • [29] Effect of Gestational Age at Tenofovir-Emtricitabine-Efavirenz Initiation on Adverse Birth Outcomes in Botswana
    Zash, Rebecca
    Rough, Kathryn
    Jacobson, Denise L.
    Diseko, Modiegi
    Mayondi, Gloria
    Mmalane, Mompati
    Essex, Max
    Petlo, Chipo
    Lockman, Shahin
    Makhema, Joseph
    Shapiro, Roger L.
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2018, 7 (03) : E148 - E151
  • [30] HERPES SIMPLEX VIRUS (HSV) INFECTION IN THE VOICE (MTN 003) STUDY: PRE-EXPOSURE PROPHYLAXIS (PREP) FOR HIV WITH DAILY USE OF ORAL TENOFOVIR, ORAL TENOFOVIR-EMTRICITABINE, OR VAGINAL TENOFOVIR GEL
    Marrazzo, J.
    Rabe, L.
    Kelly, C.
    Livant, T.
    Chirenje, M.
    Richardson, B.
    Deal, C.
    Piper, J.
    Hillier, S.
    SEXUALLY TRANSMITTED INFECTIONS, 2013, 89 : A46 - A46
12345